The 5-x Aβ species was initially described in cells expressing an APP lacking the C-terminal 31 amino acids, but has also been discovered in AD patients using a 5-x Aβ neo-epitope antibody [36,37] and in nondemented controls by mass spectometry [21]. The gene discussed is APP; the disease is Alzheimer disease.